Wugen Appoints Jan Davidson M.D., Ph.D., as Chief Medical Officer to Guide the Company's Global NK and T cell Clinical Programs
ST. LOUIS, Feb. 22, 2021 /PRNewswire/ -- Wugen Inc., a biotechnology company developing novel, universal allogeneic off-the-shelf cell therapies, today announced the appointment of…
